Adaptive Biotechnologies Corporation (MUN:1HM)
13.04
+1.11 (9.35%)
Last updated: Nov 20, 2025, 8:01 AM CET
Adaptive Biotechnologies Revenue
Adaptive Biotechnologies had revenue of $93.97M USD in the quarter ending September 30, 2025, with 102.38% growth. This brings the company's revenue in the last twelve months to $252.75M, up 42.57% year-over-year. In the year 2024, Adaptive Biotechnologies had annual revenue of $178.96M with 5.10% growth.
Revenue (ttm)
$252.75M
Revenue Growth
+42.57%
P/S Ratio
11.47
Revenue / Employee
$408.33K
Employees
619
Market Cap
2.47B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 178.96M | 8.68M | 5.10% |
| Dec 31, 2023 | 170.28M | -15.03M | -8.11% |
| Dec 31, 2022 | 185.31M | 30.96M | 20.06% |
| Dec 31, 2021 | 154.34M | 55.96M | 56.88% |
| Dec 31, 2020 | 98.38M | 13.31M | 15.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Adaptive Biotechnologies News
- 10 days ago - Chad Robins Sells 89,265 Shares of Adaptive Biotechnologies Corp - GuruFocus
- 11 days ago - Adaptive Biotechnologies (ADPT): Morgan Stanley Raises Price Target to $16 | ADPT Stock News - GuruFocus
- 16 days ago - Adaptive Biotechnologies Corporation 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 16 days ago - JP Morgan Raises Price Target for Adaptive Biotechnologies (ADPT) to $20 | ADPT Stock News - GuruFocus
- 16 days ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Adaptive Biotechnologies outlines 39%–42% MRD revenue growth outlook for 2025 with accelerating EMR integration - Seeking Alpha
- 16 days ago - Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Decoding Adaptive Biotechnologies Corp (ADPT): A Strategic SWOT Insight - GuruFocus